SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo

🎯 Drug Targets

Browse 1 drug targets with druggability analysis, composite scores, and clinical context

1
Targets
1
High Druggability
0.71
Avg Score
15
Target Classes
Druggability Distribution
High: 1Medium: 0Low: 0Unknown: 0
Avg druggability score: 0.500
Clinical Pipeline
Approved: 1Phase III: 0Phase II: 0Phase I: 0Preclinical: 0
Total compounds: 0 · Approved: 0
Class All Classes Enzyme (35) Signaling Protein (25) Structural Protein (17) Protein (16) Gpcr (13) Ion Channel (12) Transcription Factor (11) Receptor (11) Ligand (10) Transporter (8) Epigenetic Regulator (8) Kinase (7) Protease (4) Other (4) Chaperone (4)
Druggability All Druggability Low (100) Medium (62) High (14) Undruggable (6) other (3)
Sort Score Druggability Gene A-Z Market Price
Filtered by: class=kinase, druggability=High — 1 results
MTOR Mechanistic Target of Rapamycin Phase 4
Kinase High Druggability
Score
0.71
Drug.
0.50
Safety
0.50
Drugs
0
Hyps
1
Papers
20
Prioritized from 1 SciDEX hypotheses, including: APOE-Dependent Autophagy Restoration
Exchange | Dashboard